Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013557 · ClinicalTrials.gov registry record · NA
Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes
A NA study, sponsored by University of South Florida.
- Terminated
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02013557: Clinical Trial NA study, sponsored by University of South Florida.
NCT02013557 is a NA study that was terminated before completion, run by University of South Florida. The registered enrollment target is 57 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02013557, a NA study, was terminated before completion, sponsored by University of South Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery. Study Design: Prospective randomized control trial Hypothesis: Gestational diabetics will be significantly more likely to follow up with their postpartum screening for diabetes if they receive text-message reminders to set up their lab appointment compared to those who receive usual care.
Interventions
- BEHAVIORAL Text-message reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT02013557 stopped before completion
NCT02013557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Text-message reminder is the first listed.
NCT02013557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02013557 about?
NCT02013557 is a clinical study titled "Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes". Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery. Study Design: Prospective randomized control trial Hypothesis: Gestational diabetics will be significantly more likely to foll...
What is the current status of trial NCT02013557?
This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2014-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02013557?
The interventions under investigation include: Text-message reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT02013557?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02013557's enrollment target sits among peer trials
57 1261st of 2000 higher than 739 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia